Rahul Sasane
Overview
Explore the profile of Rahul Sasane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
687
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Richards K, Mantri S, Brown C, Johnsrud M, Arcona S, Sasane R
Patient Prefer Adherence
. 2024 Sep;
18:1919-1928.
PMID: 39310087
Purpose: Medication is an important component of the management of Parkinson's disease (PD), yet few studies investigate factors that inform medication decision-making from the perspective of those who use these...
2.
Richards K, Johnsrud M, Zacker C, Sasane R
Community Ment Health J
. 2024 Sep;
61(3):432-439.
PMID: 39240484
Researchers have used elements of administrative healthcare claims data (e.g., diagnosis codes and medications) to calculate rates of extrapyramidal symptoms (EPS) in patients with schizophrenia who utilize second-generation antipsychotics (SGAs)....
3.
Richards K, Johnsrud M, Zacker C, Sasane R
Patient Prefer Adherence
. 2024 Jan;
18:177-185.
PMID: 38259956
Purpose: To examine 1-year persistence with oral atypical antipsychotics (OAAPs) for Medicaid patients with schizophrenia and assess the association between OAAP persistence and hospital and emergency department (ED) resource utilization....
4.
Richards K, Johnsrud M, Zacker C, Sasane R
Adm Policy Ment Health
. 2023 Dec;
51(2):207-216.
PMID: 38071724
Oral atypical antipsychotic (OAAP) medications are the most commonly prescribed treatment for the management of schizophrenia symptoms. This retrospective study, using Medicaid claims data (2016-2020), followed patients for 12 months...
5.
Song Y, E J, Guo T, Sasane R, Arcona S, Keshava N, et al.
Clinicoecon Outcomes Res
. 2023 Aug;
15:631-643.
PMID: 37551376
Background: Studies on real-world treatment patterns and long-term economic burden of Parkinson's disease (PD) have been limited. Objective: To assess treatment patterns, healthcare resource utilization (HRU), and costs associated with...
6.
Jerry M, Arcona S, McMorrow D, Schwartz H, Princic N, Sasane R
Clinicoecon Outcomes Res
. 2023 May;
15:309-319.
PMID: 37138588
Purpose: To examine work loss and indirect costs during the three-year periods prior to and following initial diagnosis of Parkinson's disease (PD) in patients and in spouses of PD patients,...
7.
Frazer M, Arcona S, Le L, Sasane R
Clin Park Relat Disord
. 2023 Jan;
8:100173.
PMID: 36660109
Objectives: To characterize patients with Parkinson's disease (PD) who initiated dopamine agonist (DA) monotherapy, describe medication utilization and provider types, and estimate medication adherence and discontinuation rates. Methods: Retrospective study...
8.
Brown C, Kanu C, Richards K, Stevens L, Sasane R, McAneny B
Cancer Med
. 2022 Mar;
11(12):2455-2466.
PMID: 35266321
Objectives: Patients face a myriad of personal and system-based challenges in accessing breast cancer care, but less is known about access as expressed and experienced by patients themselves. The objective...
9.
Navaratnam P, Arcona S, Friedman H, Leoni M, Sasane R
Clin Park Relat Disord
. 2022 Feb;
6:100135.
PMID: 35146409
Background: Medication regimens for Parkinson's disease (PD) may change as the disease progresses, symptoms fluctuate, or medication-related adverse events occur. This study evaluated treatment trends by observation year for patients...
10.
Navaratnam P, Arcona S, Friedman H, Leoni M, Shaik S, Sasane R
Clin Park Relat Disord
. 2021 Dec;
6:100125.
PMID: 34950865
Background: Parkinson's disease (PD) management seeks to balance the benefits and harms of current medications and evolves as the disease progresses. The natural history of PD and associated patterns of...